Aztreonam (AZT), a new monobactam antibiotic, was studied for clinical efficacy in the field
of gynecologic infection. AZT was administered at a daily dose of 2 g in 2 divided doses by …

Fundamental and clinical studies on aztreonam (AZT), a new synthetic monobactam
antibiotic, were performed and following results were obtained. Concentration of AZT was …

Aztreonam (AZT), a new monobactam antibiotic, was basically and clinically applied to the
field of obstetrics and gynecology, obtaining the following results. The pelvic dead space …

Fundamental and clinical studies were performed on aztreonam (AZT), a new antibiotic with
single beta-lactam ring, with the following results. Following intravenous drip infusion of 1 g …

Aztreonam (AZT), a monobactam antibiotic, is known to have a high activity against Gram-
negative bacteria. Fundamental and clinical studies were carried out on AZT with the …

Aztreonam (AZT), a new monobactam antibiotic, was studied in obstetrics and gynecology
with the following results. The tissue concentration of AZT in the female genital organs was …

Aztreonam (AZT, E-0734), a new beta-lactam antibiotic, was fundamentally and clinically
studied. The following results were obtained. The serum and internal genital tissue levels for …

Aztreonam (AZT), a new monocyclic beta-lactam antibiotic was studied on clinical efficacy
for infectious disease in gynecological field. At about 80 minutes following intravenous …

The following results were obtained through the fundamental and clinical studies of
aztreonam (AZT), a new monobactam antibiotic, in obstetrics and gynecology. Satisfactory …

Aztreonam (SQ 26,776, AZT), a new monobactam antibiotic, was studied in obstetrics and
gynecology with the following results. For the study of tissue penetration, 1 g AZT was …